Covid-19 vaccination based on the use of biotechnologies and patient compliance: ethical and philosophical aspects


  • Andreea-Iulia Somesan "Babeş-Bolyai" University, Cluj-Napoca, Romania



covid-19 vaccination, information ethics, public health policies, pandemics management, patient compliance;


The chance to prevent undesirable medical conditions is one of the main advantages brought by the use of biotechnologies in current clinical practice. Despite the obvious and potential benefits, biotechnological based biomedical research and the market placement of these new medical products may raise several ethical issues unforeseen in the planning process for extensive implementation of this new medical field. On the one hand, there are still debates among the health professionals concerning the real impact of these medical products on the human body; on the other hand, we talk about the media communication about their effectiveness and risks. Thus, today – in the midst of a pandemic – we live an extremely tense social situation by the existence of two parties blaming each other for the gravity of the present context. Of course, responsible institutions and competent professionals should have ethical control over the development of these biomedical products. However, in addition to the research ethics and applied public health policies, we may also talk about the ethics of communication and information. Is the communication effective in the context of the present pandemic and based on solid ethical principles? What could be the correlation between violating the ethical principles of communication and practising an ineffective public health policy? This study, based on a short literature review, attempts to analyze the ethical and philosophical relationship between media discourse, public health policies and the compliance of the target population.